FTRE has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
FTRE has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Fortrea Holdings's EBITDA per Share for the three months ended in Jun. 2024 was $-0.25.
During the past 12 months, Fortrea Holdings's average EBITDA Per Share Growth Rate was -92.80% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -9.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 4 years, the highest 3-Year average EBITDA Per Share Growth Rate of Fortrea Holdings was -9.10% per year. The lowest was -9.10% per year. And the median was -9.10% per year.
For the Biotechnology subindustry, Fortrea Holdings's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Fortrea Holdings's 5-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Fortrea Holdings's 5-Year EBITDA Growth Rate falls into.
This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
Fortrea Holdings (NAS:FTRE) 5-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.
Thank you for viewing the detailed overview of Fortrea Holdings's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.
Thomas Pike | officer: Chief Executive Officer | C/O ACCENTURE, 161 N. CLARK STREET, 23RD FLOOR, CHICAGO IL 60601 |
Peter M Neupert | director | 13920 SE EASTGATE WAY, STE 300, BELLEVUE WA 98005 |
Betty D Larson | director | GE HEALTHCARE TECHNOLOGIES INC., 500 W. MONROE, CHICAGO IL 60661 |
R Andrew Eckert | director | THREE RAVINIA DRIVE, ATLANTA GA 30346 |
Edward A Pesicka | director | 9120 LOCKWOOD BLVD, MECHANICSVILLE VA 23116 |
Amrit Ray | director | 60 LEVERONI COURT, NOVATO CA 94949 |
Amanda M. Warren | officer: Chief Accounting Officer | 8 MOORE DRIVE, DURHAM NC 27703 |
David Ross Smith | director | 251 BALLARDVALE STREET, WILMINGTON MA 01887 |
Van Der Vaart Sandra D | director, officer: President and Secretary | 531 SOUTH SPRING STREET, BURLINGTON NC 27215 |
Glenn A Eisenberg | director, officer: Executive Vice President | P O BOX 1017, CHARLOTTE NC 28201-1017 |
James S. Hanson | officer: General Counsel | 79 TW ALEXANDER DRIVE, 4501 RESEARCH COMMONS, SUITE 100, RESEARCH TRIANGLE PARK NC 27709 |
Laboratory Corp Of America Holdings | 10 percent owner | 358 S MAIN ST, BURLINGTON NC 27215 |
Jill G. Mcconnell | officer: Chief Financial Officer | 8 MOORE DRIVE, DURHAM NC 27703 |
Mark A. Morais | officer: Chief Operating Officer | 8 MOORE DRIVE, DURHAM NC 27703 |
Robert S. Pringle | officer: Treasurer | 531 SOUTH SPRING STREET, BURLINGTON NC 27215 |
From GuruFocus
By Marketwired • 10-13-2023
By Business Wire • 10-17-2023
By Marketwired • 10-10-2023
By Marketwired • 10-11-2023
By Marketwired • 09-06-2023
By Marketwired • 08-14-2023
By Marketwired • 07-20-2023
By GuruFocus Research • 11-13-2023
By Stavros Georgiadis, CFA • 08-15-2023
By Marketwired • 09-06-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.